Bluegrass Vascular

Bluegrass Vascular is a commercial-stage medical device company focused on solving critical vascular access challenges. Its core technology, the Surfacer System, enables a 'Don't Go Left' approach to restore central venous access in patients with venous occlusions, aiming to improve outcomes for dialysis patients and reduce healthcare costs. Led by an experienced management team with a track record in device development and commercialization, the company is positioned in the large and growing end-stage renal disease market. Its success hinges on physician adoption, reimbursement strategies, and navigating competition from alternative vascular access techniques.

Proprietary Inside-Out® access technique for restoring central venous access through occluded veins via a minimally invasive, catheter-based system.

Competition includes traditional endovascular techniques (angioplasty, stenting) for venous occlusions, surgical bypass procedures, and alternative catheter placement strategies. The company also competes indirectly with technologies aimed at preventing catheter-related complications or facilitating early fistula creation. Larger medtech firms with vascular access portfolios are potential competitors or acquirers.